High-Density Lipoprotein Deficiency and Dyslipoproteinemia Associated With Venous Thrombosis in Men
- 9 August 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 112 (6) , 893-899
- https://doi.org/10.1161/circulationaha.104.521344
Abstract
Although dyslipoproteinemia is associated with arterial atherothrombosis, little is known about plasma lipoproteins in venous thrombosis patients. We determined plasma lipoprotein subclass concentrations using nuclear magnetic resonance spectroscopy and antigenic levels of apolipoproteins AI and B in blood samples from 49 male venous thrombosis patients and matched controls aged <55 years. Venous thrombosis patients had significantly lower levels of HDL particles, large HDL particles, HDL cholesterol, and apolipoprotein AI and significantly higher levels of LDL particles and small LDL particles. The quartile-based odds ratios for decreased HDL particle and apolipoprotein AI levels in patients compared with controls were 6.5 and 6.0 (95% CI, 2.3 to 19 and 2.1 to 17), respectively. Odds ratios for apolipoprotein B/apolipoprotein AI ratio and LDL cholesterol/HDL cholesterol ratio were 6.3 and 2.7 (95% CI, 1.9 to 21 and 1.1 to 6.5), respectively. When polymorphisms in genes for hepatic lipase, endothelial lipase, and cholesteryl ester transfer protein were analyzed, patients differed significantly from controls in the allelic frequency for the TaqI B1/B2 polymorphism in cholesteryl ester transfer protein, consistent with the observed pattern of lower HDL and higher LDL. Venous thrombosis in men aged <55 years old is associated with dyslipoproteinemia involving lower levels of HDL particles, elevated levels of small LDL particles, and an elevated ratio of apolipoprotein B/apolipoprotein AI. This dyslipoproteinemia seems associated with a related cholesteryl ester transfer protein genotype difference.Keywords
This publication has 36 references indexed in Scilit:
- High risk of recurrent venous thromboembolism in menJournal of Thrombosis and Haemostasis, 2004
- Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham StudyClinical Chemistry, 2004
- Natural genetic variation as a tool in understanding the role of CETP in lipid levels and diseaseJournal of Lipid Research, 2003
- Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C->A polymorphism and a novel promoter variant are independently associated with CETP concentrationHuman Molecular Genetics, 2003
- Cholesteryl Ester Transfer Protein Taq I B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL DeficiencyArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Neutral Glycosphingolipid-dependent Inactivation of Coagulation Factor Va by Activated Protein C and Protein SJournal of Biological Chemistry, 2002
- Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in menEuropean Journal of Clinical Investigation, 2000
- Deep-vein thrombosisThe Lancet, 1999
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983